These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 24041692

  • 21. Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.
    Ding L, Liou GY, Schmitt DM, Storz P, Zhang JS, Billadeau DD.
    J Pathol; 2017 Sep; 243(1):65-77. PubMed ID: 28639695
    [Abstract] [Full Text] [Related]

  • 22. Molecular genetics of pancreatic intraepithelial neoplasia.
    Feldmann G, Beaty R, Hruban RH, Maitra A.
    J Hepatobiliary Pancreat Surg; 2007 Sep; 14(3):224-32. PubMed ID: 17520196
    [Abstract] [Full Text] [Related]

  • 23. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.
    Lange AW, Molkentin JD, Yutzey KE.
    Dev Biol; 2004 Feb 15; 266(2):346-60. PubMed ID: 14738882
    [Abstract] [Full Text] [Related]

  • 24. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, Eshleman JR.
    Mol Cancer Res; 2009 Feb 15; 7(2):230-6. PubMed ID: 19208745
    [Abstract] [Full Text] [Related]

  • 25. Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes.
    Kyttälä S, Habermann I, Minami T, Ehninger G, Kiani A.
    Br J Haematol; 2009 Feb 15; 144(3):395-408. PubMed ID: 19036088
    [Abstract] [Full Text] [Related]

  • 26. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma.
    Mazur PK, Einwächter H, Lee M, Sipos B, Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G, Schmid RM, Siveke JT.
    Proc Natl Acad Sci U S A; 2010 Jul 27; 107(30):13438-43. PubMed ID: 20624967
    [Abstract] [Full Text] [Related]

  • 27. Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.
    Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, Tucker RD, Boca SM, Jermusyck A, Collins I, Vietsch EE, Pierobon M, Hodge KA, Cui W, Amundadottir LT, Petricoin E, Shivapurkar N, Smith JP.
    Pancreas; 2019 Aug 27; 48(7):894-903. PubMed ID: 31268978
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, Naito Z.
    Int J Oncol; 2011 Jan 27; 38(1):133-43. PubMed ID: 21109934
    [Abstract] [Full Text] [Related]

  • 29. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
    Garcia MN, Grasso D, Lopez-Millan MB, Hamidi T, Loncle C, Tomasini R, Lomberk G, Porteu F, Urrutia R, Iovanna JL.
    J Clin Invest; 2014 Nov 27; 124(11):4709-22. PubMed ID: 25250570
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
    Zhang Z, Li H, Deng Y, Schuck K, Raulefs S, Maeritz N, Yu Y, Hechler T, Pahl A, Fernández-Sáiz V, Wan Y, Wang G, Engleitner T, Öllinger R, Rad R, Reichert M, Diakopoulos KN, Weber V, Li J, Shen S, Zou X, Kleeff J, Mihaljevic A, Michalski CW, Algül H, Friess H, Kong B.
    Gastroenterology; 2021 Nov 27; 161(5):1601-1614.e23. PubMed ID: 34303658
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
    Stellas D, Szabolcs M, Koul S, Li Z, Polyzos A, Anagnostopoulos C, Cournia Z, Tamvakopoulos C, Klinakis A, Efstratiadis A.
    J Natl Cancer Inst; 2014 Dec 27; 106(12):. PubMed ID: 25306215
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
    Lanza-Jacoby S, Yan G, Radice G, LePhong C, Baliff J, Hess R.
    Exp Biol Med (Maywood); 2013 Jul 27; 238(7):787-97. PubMed ID: 23828595
    [Abstract] [Full Text] [Related]

  • 35. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct 27; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
    Flandez M, Cendrowski J, Cañamero M, Salas A, del Pozo N, Schoonjans K, Real FX.
    Gut; 2014 Apr 27; 63(4):647-55. PubMed ID: 23598351
    [Abstract] [Full Text] [Related]

  • 38. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Mohammed A, Janakiram NB, Brewer M, Duff A, Lightfoot S, Brush RS, Anderson RE, Rao CV.
    Neoplasia; 2012 Dec 27; 14(12):1249-59. PubMed ID: 23308056
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.